- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 243.35M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.97B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.98B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.06B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.12B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $10.82B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $10.64B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.17B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.34B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.51B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.61B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.08B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.1B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.56B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $16.49B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 243.02M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $15M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $88M |
| Capex | Q1 2025 · Mar 31, 2024 | $74M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $89M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.63 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.63 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $474M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $59M |
| Net Income | Q1 2025 · Mar 31, 2024 | $153M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $209M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $752M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.28B |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.03B |